An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy

被引:0
|
作者
De Caro, Francesco [1 ,2 ,3 ]
Pecoraro, Nadia [1 ]
Capunzo, Mario [2 ,3 ]
Caruccio, Simona [2 ]
Caggiano, Filippo [3 ]
Cersosimo, Giuseppina [4 ]
Costantino, Maria [2 ,3 ]
Longanella, Walter [3 ]
Malatesta, Francesca [1 ]
Tomeo, Matteo [2 ]
Savarese, Giulia [2 ]
Sinopoli, Pio [2 ]
Vozzella, Emilia Anna [3 ]
Moccia, Giuseppina [1 ]
机构
[1] Univ Salerno, Dept Med & Surg & Dent, Publ Hlth Lab Anal Community Hlth Needs, Baronissi Campus, I-84081 Baronissi, Italy
[2] Univ Salerno, Dept Med Surg & Dent, Baronissi Campus, I-84081 Baronissi, Italy
[3] Hosp San Giovanni Dio & Ruggi Aragona, I-84131 Salerno, Italy
[4] Univ Salerno, Dept Polit & Social Studies, I-84084 Fisciano, Italy
来源
PATHOGENS | 2025年 / 14卷 / 02期
关键词
Herpes Zoster; illness representations; vaccination; hospital vaccination; fragile patients; vaccinal campaigns; vaccine hesitancy; SUBUNIT VACCINE; EFFICACY;
D O I
10.3390/pathogens14020145
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the context of the Italian National Herpes Zoster Vaccine program, an exploratory survey was conducted on a sample of fragile adult patients to investigate the representations of the disease and its prevention to build future local vaccination campaigns. An ad hoc questionnaire was administered to 271 fragile adult patients who had adjuvanted recombinant Herpes Zoster vaccination to detect the following: knowledge and perception of the disease and its risks; information sources and confidence in the information sources used; and perception of the Herpes Zoster vaccination. Fragile adult patients have the representation of Herpes Zoster as a serious disease (86.5%), and they consider themselves informed concerning symptoms and health effects. Women are more fearful of the impact of the disease (Chi-square = 10.03; DF = 3; p-value = 0.018), while those with a higher average age consider themselves less informed (R = -158; p-value = 0.039). The sources of information that contributed to the construction of illness representation are health personnel (73.5%), followed by the web and social web (14.7%), and media such as radio and TV (10.0%). Regarding the vaccine representation, fragile patients are confident about the vaccine and the science behind it and believe everyone should receive it. However, a high percentage (62.9%) fear side effects. Our analysis highlights that vaccination campaigns must be planned based on the target audience, individual and contextual needs, and representations of the disease, particularly when dealing with frail patients, to implement effective preventive interventions.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study
    Hawkins, Kellie L.
    Gordon, Kirsha S.
    Levin, Myron J.
    Weinberg, Adriana
    Battaglia, Catherine
    Rodriguez-Barradas, Maria C.
    Brown, Sheldon T.
    Rimland, David
    Justice, Amy
    Tate, Janet
    Erlandson, Kristine M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 79 (04) : 527 - 533
  • [42] Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
    Curran, Desmond
    Van Oorschot, Desiree
    Varghese, Lijoy
    Oostvogels, Lidia
    Mrkvan, Tomas
    Colindres, Romulo
    von Krempelhuber, Alfred
    Anastassopoulou, Anastassia
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (10) : 2213 - 2221
  • [43] Healthy ageing: Herpes zoster infection and the role of zoster vaccination
    Curran, Desmond
    Doherty, T. Mark
    Lecrenier, Nicolas
    Breuer, Thomas
    NPJ VACCINES, 2023, 8 (01)
  • [44] Reducing the burden of herpes zoster in Italy
    Gabutti, Giovanni
    Franco, Elisabetta
    Bonanni, Paolo
    Conversano, Michele
    Ferro, Antonio
    Lazzari, Marzia
    Maggi, Stefania
    Rossi, Alessandro
    Scotti, Silvestro
    Vitale, Francesco
    Volpi, Antonio
    Greco, Donato
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (01) : 101 - 107
  • [45] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Le, Phuc
    Rothberg, Michael B.
    JAMA INTERNAL MEDICINE, 2018, 178 (02) : 248 - 258
  • [46] Herpes Zoster and COVID-19 Vaccination: A Narrative Review
    Potestio, Luca
    Megna, Matteo
    Villani, Alessia
    Cacciapuoti, Sara
    Scalvenzi, Massimiliano
    Martora, Fabrizio
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3323 - 3331
  • [47] Cost and health impact analysis of herpes zoster vaccination in Norway
    Flem, Elmira
    Graham, Jonathan
    Yi, Zinan
    Wisloff, Torbjorn
    Johnson, Kelly D.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (02) : 315 - 326
  • [48] Herpes zoster in the context of varicella vaccination - An equation with several variables
    Wutzler, Peter
    Casabona, Giacomo
    Cnops, Jennifer
    Akpo, Esse Ifebi Herve
    Safadi, Marco Aurelio P.
    VACCINE, 2018, 36 (46) : 7072 - 7082
  • [49] RF-New Recombinant Vaccine for the Prevention of Herpes Zoster
    Morgado-Carrasco, D.
    Fusta-Novell, X.
    Giavedoni, P.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (01): : 67 - 68
  • [50] The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain
    Garcia, Andrea
    Vallejo-Aparicio, Laura Amanda
    Martinez, Rosario Cambronero
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)